Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,173.91
(
0.12%
)
US TECH 100
26,224.80
(
-1.30%
)
Dow Jones
49,310.32
(
0.00%
)
Brent Oil
105.26
(
3.08%
)
Bitcoin
76,259.05
(
-1.44%
)
News Focus
News Focus

Replies to post #1066 on Idenix Pharmaceuticals (IDIX)

Replies to #1066 on Idenix Pharmaceuticals (IDIX)
icon url

DewDiligence

05/18/07 5:43 PM

#1067 RE: gofishmarko #1066

???

Baraclude is effectively out of the running for Lamivudine-resistant patients. The battle will be between Hepsera, Telbivudine, and perhaps some newer agents.